These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 658614)

  • 21. Hyperinsulinemia and abdominal obesity affect the expression of hypertriglyceridemia in heterozygous familial lipoprotein lipase deficiency.
    Julien P; Vohl MC; Gaudet D; Gagné C; Lévesque G; Després JP; Cadelis F; Brun LD; Nadeau A; Ven Murthy MR
    Diabetes; 1997 Dec; 46(12):2063-8. PubMed ID: 9392497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fatty liver disease, insulin resistance and adiponectin in an obese pediatric population].
    López-Capapé M; López-Bermejo A; Alonso Blanco M; Lara Orejas E; Corbatón Blasco J; Barrio Castellanos R
    An Pediatr (Barc); 2009 Dec; 71(6):495-501. PubMed ID: 19850541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of obesity in primary hyperlipidemias.
    Carmena R; Ascaso JF; Real JT
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):354-9. PubMed ID: 11887432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma triglyceride and insulin levels in familial hypertriglyceridemia.
    Brunzell JD; Bierman EL
    Ann Intern Med; 1977 Aug; 87(2):198-9. PubMed ID: 889202
    [No Abstract]   [Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease is associated with hyperlipidemia and obesity.
    Sharabi Y; Eldad A
    Am J Med; 2000 Aug; 109(2):171. PubMed ID: 11032566
    [No Abstract]   [Full Text] [Related]  

  • 26. Central obesity in rhesus monkeys: association with hyperinsulinemia, insulin resistance and hypertriglyceridemia?
    Bodkin NL; Hannah JS; Ortmeyer HK; Hansen BC
    Int J Obes Relat Metab Disord; 1993 Jan; 17(1):53-61. PubMed ID: 8383642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity.
    Psyrogiannis AJ; Alexopoulos DK; Kyriazopoulou VE; Vagenakis AG
    Angiology; 1998 Aug; 49(8):607-12. PubMed ID: 9717889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in insulin secretion in familial combined hyperlipemia].
    Ascaso JF; Sales J; Priego A; Merchante A; Carmena-Ramón R; Carmena R
    Med Clin (Barc); 1997 Apr; 108(14):530-3. PubMed ID: 9190437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin secretion and peripheral insulin sensitivity in obese children. Evidence of deficient glucose-stimulated early insulin release despite hyperinsulinemia.
    Häger A; Thorell JI
    Int J Obes; 1979; 3(4):349-57. PubMed ID: 393648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of insulin in endogenous hypertriglyceridemia.
    Reaven GM; Lerner RL; Stern MP; Farquhar JW
    J Clin Invest; 1967 Nov; 46(11):1756-67. PubMed ID: 6061748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for diabetes mellitus and genetic forms of hypertriglyceridemia as independent entities.
    Brunzell JD; Hazzard WR; Motulsky AG; Bierman EL
    Metabolism; 1975 Oct; 24(10):1115-21. PubMed ID: 1165727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypertriglyceridemia, diabetes mellitus, and coronary vessel disease.
    Levy RI; Glueck CJ
    Arch Intern Med; 1969 Mar; 123(3):220-8. PubMed ID: 4886256
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic deficiency of apolipoprotein D in the mouse is associated with nonfasting hypertriglyceridemia and hyperinsulinemia.
    Jiménez-Palomares M; Cózar-Castellano I; Ganfornina MD; Sánchez D; Perdomo G
    Metabolism; 2011 Dec; 60(12):1767-74. PubMed ID: 21632073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interrelationships of hyperinsulinism and hypertriglyceridemia in young patients with coronary heart disease.
    Tzagournis M; Chiles R; Ryan JM; Skillman TG
    Circulation; 1968 Dec; 38(6):1156-63. PubMed ID: 5721965
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between disease severity, hyperinsulinemia, and impaired insulin clearance in patients with nonalcoholic steatohepatitis.
    Bril F; Lomonaco R; Orsak B; Ortiz-Lopez C; Webb A; Tio F; Hecht J; Cusi K
    Hepatology; 2014 Jun; 59(6):2178-87. PubMed ID: 24777953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Plasma insulin changes in obesity with or without abnormal glucose tolerance].
    García Pascual IJ; González Ruiz JM
    An Med Interna; 1993 Oct; 10(10):473-8. PubMed ID: 8136423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity.
    Bagdade JD; Porte D; Brunzell JD; Bierman EL
    J Lab Clin Med; 1974 Apr; 83(4):563-9. PubMed ID: 4817780
    [No Abstract]   [Full Text] [Related]  

  • 38. Diabetic hypertriglyceridemia: evidence for three clinical syndromes.
    Reaven GM; Greenfield MS
    Diabetes; 1981; 30(Suppl 2):66-75. PubMed ID: 7028540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiologic changes in obesity.
    Angel A
    Can Med Assoc J; 1978 Dec; 119(12):1401-6. PubMed ID: 737617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance.
    Yamada N; Yoshinaga H; Sakurai N; Shimano H; Gotoda T; Ohashi Y; Yazaki Y; Kosaka K
    Diabetes Care; 1994 Feb; 17(2):107-14. PubMed ID: 8137680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.